BSX earnings: next report 2026-07-29, real EPS beat/miss history, analyst consensus Buy, P/E 17.90. Updated 2026-07-23.
Boston Scientific (BSX) Research Hub
Boston Scientific (BSX) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 42.98 USD (-4.40%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 17.90, market cap 63.73B. This hub links to the full technical, earnings and options research available for BSX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, US |
| Last close | 42.98 USD (-4.40%) |
| 52-week range | 42.2 USD – 52.56 USD |
| Trend regime | Range |
| 14-day RSI | 30.7 (Bearish) |
| Trailing P/E | 17.90 |
| Market cap | 63.73B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for BSX
Covered Call on BSX: how it works, illustrative setup around the real 42.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BSX: how it works, illustrative setup around the real 42.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BSX: how it works, illustrative setup around the real 42.98 USD price, max profit/loss, breakeven and when to use it. Educational.
BSX technical analysis: range, last 42.98 USD, RSI 30.7, 52w range 42.2 USD–52.56 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BSX in?
Boston Scientific (BSX) is classified under Healthcare (Medical - Devices), listed on NYSE, US.
Is BSX in an uptrend or downtrend?
As of 2026-09-11, BSX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BSX's trailing P/E ratio?
BSX's trailing P/E is 17.90, with a market cap of 63.73B. See the earnings research page for full valuation detail.
When does BSX next report earnings?
BSX is next scheduled to report earnings on 2026-07-29, with a consensus EPS estimate of 0.828 USD.